Compare WVE & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | WB |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | 2015 | 2014 |
| Metric | WVE | WB |
|---|---|---|
| Price | $13.40 | $10.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 1 |
| Target Price | ★ $29.94 | $14.00 |
| AVG Volume (30 Days) | ★ 4.0M | 978.0K |
| Earning Date | 03-03-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 15.06% |
| EPS Growth | N/A | ★ 20.16 |
| EPS | N/A | ★ 1.76 |
| Revenue | $109,230,000.00 | ★ $1,740,785,000.00 |
| Revenue This Year | N/A | $0.53 |
| Revenue Next Year | $16.20 | $2.38 |
| P/E Ratio | ★ N/A | $6.20 |
| Revenue Growth | ★ 103.75 | N/A |
| 52 Week Low | $5.28 | $7.10 |
| 52 Week High | $21.73 | $12.96 |
| Indicator | WVE | WB |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 54.59 |
| Support Level | $13.22 | $10.52 |
| Resistance Level | $14.51 | $11.10 |
| Average True Range (ATR) | 1.33 | 0.27 |
| MACD | -0.38 | 0.01 |
| Stochastic Oscillator | 3.18 | 44.26 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.